Last $7.31 USD
Change Today +0.24 / 3.39%
Volume 906.6K
ACHN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 12:34 PM 07/29/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - achillion pharmaceuticals (ACHN)

Name (Connections)Board RelationshipsTitleKey Developments
Robert Van Nostrand BS 32 RelationshipsDirector, Chairman of Audit Committee and Member of Compensation Committee 
Gary Frashier M.B.A., P.E. 20 RelationshipsDirector, Chairman of Compensation Committee and Member of Audit Committee 
Jason Fisherman M.D., MBA 63 RelationshipsDirector, Member of Audit Committee and Member of Strategy & Corporate Development Committee 

Compensation Committee* - achillion pharmaceuticals (ACHN)

Name (Connections)Board RelationshipsTitle
Gary Frashier M.B.A., P.E. 20 RelationshipsDirector, Chairman of Compensation Committee and Member of Audit Committee
Kurt Graves 47 RelationshipsIndependent Director, Member of Compensation Committee, Member of Nominating & Corporate Governance Committee and Member of Strategy & Corporate Development Committee
David Scheer 44 RelationshipsChairman, Chairman of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Strategy & Corporate Development Committee
Robert Van Nostrand BS 32 RelationshipsDirector, Chairman of Audit Committee and Member of Compensation Committee
ACHN Compensation vs. Industry
435.6K
373.4K
Chief Executive Officer
326.4K
274.0K
Chief Financial Officer
Share price activity for ACHILLION PHARMACEUTICALS (ACHN)
52 Week Price Performance
ACHN
Industry Average

Nominating Committee* - achillion pharmaceuticals (ACHN)

Name (Connections)Board RelationshipsTitleKey Developments
David Scheer 44 RelationshipsChairman, Chairman of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Strategy & Corporate Development CommitteeAchillion Announces Management Changes
03/7/14
Nicole Vitullo M.B.A. 62 RelationshipsDirector and Member of Nominating & Corporate Governance CommitteeAchillion Pharmaceuticals, Inc. Announces Management Changes
05/28/13
Kurt Graves 47 RelationshipsIndependent Director, Member of Compensation Committee, Member of Nominating & Corporate Governance Committee and Member of Strategy & Corporate Development CommitteeAchillion Pharmaceuticals, Inc. Announces Executive Appointments
05/15/13

Corporate Governance Committee* - achillion pharmaceuticals (ACHN)

Name (Connections)Board RelationshipsTitle
Kurt Graves 47 RelationshipsDirector, Chairman of Compensation Committee and Member of Audit Committee
David Scheer 44 RelationshipsIndependent Director, Member of Compensation Committee, Member of Nominating & Corporate Governance Committee and Member of Strategy & Corporate Development Committee
Nicole Vitullo M.B.A. 62 RelationshipsChairman, Chairman of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Strategy & Corporate Development Committee
ACHN and Competitor
Insiders vs. External
Board
11%
89%
Achillion Pharmaceuticals, Inc.
Insiders
External Board Members

Management/Organization Development Committee* - achillion pharmaceuticals (ACHN)

Name(Connections)Board RelationshipsTitle
Jason Fisherman M.D., MBA 63 RelationshipsDirector, Member of Audit Committee and Member of Strategy & Corporate Development Committee
Kurt Graves 47 RelationshipsIndependent Director, Member of Compensation Committee, Member of Nominating & Corporate Governance Committee and Member of Strategy & Corporate Development Committee
Michael Kishbauch 26 RelationshipsDirector and Chairman of Strategy & Corporate Development Committee
David Scheer 44 RelationshipsChairman, Chairman of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Strategy & Corporate Development Committee
Rank Against Competitors
Revenue/Employee
$32.8B-32768
Earnings/Employee
$975.0K-32768
K = Thousand
M = Million
B = Billion
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACHN:US $7.31 USD +0.24

ACHN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ACHN.
View Industry Companies
 

Industry Analysis

ACHN

Industry Average

Valuation ACHN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 5.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACHILLION PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.